Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OT 1

OT 1

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRROLIDIN-3-ONE O-METHYLOXIME USEFUL IN METHODS OF TREATING CONDITIONS RELATED TO THE OT-R ACTIVITY
EP 3164384 B1Applicant: OBSEVA SAPriority: 2014
CN
EP
US
WO
10 publications
benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP 1449844 A1Applicant: FERRING BVPriority: 2003
EP
US
4 publications
NOVEL TREATMENT OF MULTIPLE SCLEROSIS (MS)
WO 2012059541 A1Applicant: UNIV JW GOETHE FRANKFURT MAINPriority: 2010
CN
WO
2 publications
CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS
US 2015051183 A1Applicant: POLYPHOR AGPriority: 2012
CN
US
2 publications
New indole derivatives and their use as medicine
EP 1939195 A1Applicant: AETERNA ZENTARIS GMBHPriority: 2001
EP
2 publications
Fungicidal triazolopyrimidines, process for their preparation, their use for combatting fungi and agents comprising them
EP 1616870 A1Applicant: BASF AGPriority: 2002
EP
2 publications
Quinazolines as MMP-13 inhibitors
US 2002193377 A1Applicant: ANDRIANJARA CHARLESPriority: 2002
US
Pharmaceutically active oligosaccharide conjugates
US 2006100163 A1Applicant: ORLANDO MICHELEPriority: 2002
US
Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
EP 2332924 A1Applicant: BOEHRINGER INGELHEIM PHARMAPriority: 2002
EP
4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases
EP 2298305 A1Applicant: BOEHRINGER INGELHEIM PHARMAPriority: 2003
EP

Page 1 of 3